Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. develops medical technology for spine surgery, with a business centered on procedural spine solutions, surgical instrumentation, imaging, navigation and informatics. Company updates commonly address surgical revenue trends, EOS revenue, surgeon adoption, product launches such as Valence and EOS Insight, and the continued development of its InformatiX platform through subsidiaries including Alphatec Spine, EOS imaging and SafeOp Surgical.
Recurring developments also include financing actions, credit-facility activity, strategic partnerships tied to spinal fusion and regenerative technology, profitability metrics and annual outlook updates. Governance items, including board composition changes, appear alongside operating results and capital-structure announcements.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Alphatec Holdings, Inc. (NASDAQ: ATEC) has announced the pricing of an underwritten registered offering of 4,285,715 shares of common stock at a price of $14.00 per share. This move is expected to generate approximately $60 million in gross proceeds before underwriting discounts and commissions. The offering is scheduled to close on or about April 21, 2023, and the shares are being offered under a shelf registration statement that was declared effective on April 19, 2023. TD Cowen is the sole book-runner for this offering. ATEC is focused on innovative solutions for spine surgery, aiming to enhance surgical goals with its Organic Innovation Machine™ and AlphaInformatiX Platform.
Alphatec Holdings, a spine surgery solution provider, has acquired the REMI Robotic Navigation System from Fusion Robotics for $55 million. This acquisition aims to enhance ATEC’s procedural strategy by integrating advanced navigation and robotics into spinal workflows. The company expects total revenue to exceed $108 million in Q1 2023, reflecting over 52% year-over-year growth. Additionally, ATEC has raised its full-year revenue guidance to $450 million, a 28% increase from the previous year. The firm anticipates achieving break-even adjusted EBITDA in 2023 and free cash flow in 2025. A live webcast will discuss these developments, scheduled for today at 2:00 PM PT.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced it will release its first quarter financial results on May 4, 2023, after the market closes. A live webcast will be hosted at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the webcast by visiting ATEC's Investor Relations Section. Following the webcast, a replay will be available for twelve months on the website, with a dial-in replay option starting two hours after the event. ATEC focuses on revolutionizing spine surgery with innovative solutions, emphasizing their Organic Innovation Machine™ and expanding AlphaInformatiX Platform.